New York, NY, United States of America

Mark M Moasser


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):

Title: Mark M Moasser: Innovator in Cancer Treatment

Introduction

Mark M Moasser is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on developing effective therapies that combine various therapeutic agents to combat cancer.

Latest Patents

Mark M Moasser holds a patent for a method of treating cancer. The patent describes a novel approach that involves using a combination of an antineoplastic agent and an inhibitor of prenyl-protein transferase. This method comprises administering these therapeutic agents either sequentially or simultaneously to achieve optimal treatment outcomes. The invention also includes methods for preparing such compositions, showcasing his commitment to advancing cancer therapies. He has 1 patent to his name.

Career Highlights

Mark M Moasser is affiliated with the Sloan Kettering Institute for Cancer Research, where he conducts groundbreaking research in oncology. His work has been instrumental in developing new treatment strategies that enhance the efficacy of cancer therapies. His dedication to improving patient outcomes is evident in his innovative approaches to cancer treatment.

Collaborations

Throughout his career, Mark has collaborated with esteemed colleagues, including Neal Rosen and Laura Sepp-Lorenzino. These collaborations have fostered a rich environment for research and innovation, contributing to advancements in cancer treatment.

Conclusion

Mark M Moasser is a key figure in the field of cancer research, with a focus on innovative treatment methods. His contributions through patents and collaborations highlight his commitment to improving cancer therapies and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…